1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,636 | 0,660 | 13:16 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| THERACLION Aktie jetzt für 0€ handeln | |||||
| Do | Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up | 218 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 09.12.25 | Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements | 414 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.10.25 | Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results | 385 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 21.10.25 | Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China | 292 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 10.10.25 | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 370 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Place de cotation: Euronext Growth Paris
Éligible PEA PME
Code ISIN:... ► Artikel lesen | |
| 24.09.25 | Theraclion: Sonovein Receives MDR Certification, Strengthening Its Commercial Potential | 323 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 15.09.25 | Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate | 289 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915148081/en/Sonovein redefines varicose vein treatment with advanced... ► Artikel lesen | |
| 25.07.25 | Theraclion Growth Up in S1 2025 | 652 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725366467/en/Sonovein®, the first and only non-invasive varicose veins... ► Artikel lesen | |
| 29.04.25 | Theraclion Announces Financial Results 2024 and Reviews Progress | 505 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 26.03.25 | Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance | 645 | Business Wire | Issuance of warrants for bonds convertible into shares, in accordance with Theraclion's commitment, to investors who have requested them, for a maximum amount of 580,000 euros. 290,000... ► Artikel lesen | |
| 20.02.25 | Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan | 703 | Business Wire | Reserved issuance of warrants for convertible bonds based on a fixed price per share of 0.20 euros (without discount), for a maximum amount of €6 million, benefiting Furui and Unigestion, the... ► Artikel lesen | |
| 11.02.25 | Theraclion Announces Treatment of First Patients With New SONOVEIN 'SpeedPulse' Feature Accelerating Treatment | 512 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 07.02.25 | Theraclion: Publication of Adjusted Accounts for the First Half of 2024 | 625 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 25,600 | -0,16 % | BERENBERG stuft GERRESHEIMER AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Gerresheimer auf "Hold" mit einem Kursziel von 30 Euro belassen. 2025 sei ein weiteres durchwachsenes Jahr für den Medizintechnik-/Life-Sciences-Sektor... ► Artikel lesen | |
| MCKESSON | 687,20 | +0,03 % | MARKTALARM: EchoIQ rettet Leben - Anerkennung kommt JETZT | ||
| INMODE | 13,290 | -0,78 % | Steel Partners Targets InMode, Citing Stock Underperformance | ||
| HCA HEALTHCARE | 405,70 | +0,70 % | HCA Healthcare, Inc. Q4 Profit Increases, Beats Estimates | WASHINGTON (dpa-AFX) - HCA Healthcare, Inc. (HCA) announced earnings for its fourth quarter that Increased from the same period last year and beat the Street estimates.The company's earnings... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 426,00 | +0,95 % | EQS-DD: Limes Schlosskliniken AG: GMF Capital GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.12.2025 / 11:21... ► Artikel lesen | |
| BEYOND AIR | 1,240 | 0,00 % | Beyond Air Appoints Dan Moorhead as Chief Financial Officer | GARDEN CITY, N.Y., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 15,300 | 0,00 % | HEALTHCARE SERVICES GROUP INC - 10-Q, Quarterly Report | ||
| INTERPACE BIOSCIENCES | 1,040 | -7,14 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners | PARSIPPANY, NJ, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) ("Interpace" or the "Company") today announced that it has fully repaid its outstanding term loan facility... ► Artikel lesen | |
| MODERN DENTAL | 0,615 | -0,81 % | MODERN DENTAL Surges 12% to 4-Yr+ High After Hillhouse Investment Confirmed to Have Bought 17% Stake | ||
| IVF HARTMANN | 156,00 | -1,27 % | IVF Hartmann ernennt Interims-CEO Martin Walther definitiv zum Chef | Neuhausen am Rheinfall - Beim Medizinalbedarf-Hersteller IVF Hartmann wird Martin Walther länger auf dem Chefposten sitzen als zunächst geplant. Er wird per 1. April 2026 den CEO-Posten dauerhaft übernehmen... ► Artikel lesen | |
| ADDUS HOMECARE | 83,50 | -0,60 % | Major Decision: Darby Anderson Exercises Options, Realizing $1.75M At Addus HomeCare | ||
| ICU MEDICAL | 124,00 | -0,80 % | KeyBanc reiterates Overweight rating on ICU Medical stock, sees growth | ||
| ACADIA HEALTHCARE | 10,600 | 0,00 % | Acadia Healthcare: CEO Christopher Hunter scheidet aus, Details zur Abfindung bekannt gegeben | ||
| XYLO TECHNOLOGIES | 5,070 | -1,74 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.08.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.08.2025ISIN NameCA1079302081 BRIACELL... ► Artikel lesen | |
| VITRUVIA MEDICAL | 1,300 | 0,00 % | EQS-Adhoc: Vitruvia Medical AG: Erfolgreiche Kapitalerhöhung und Stärkung der Finanzstruktur | EQS-Ad-hoc: Vitruvia Medical AG / Schlagwort(e): Kapitalerhöhung/Kapitalmaßnahme
Vitruvia Medical AG: Erfolgreiche Kapitalerhöhung und Stärkung der Finanzstruktur
15.12.2025... ► Artikel lesen |
THERACLION gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,654 Euro und damit -14,62 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION finden Sie auf Wallstreet Online.